TrialInternational journal of hematology2025
Association between gene mutations and outcomes in Japanese high-risk AML patients: a phase 1/2 study of NS-87/CPX-351.
Hideki Makishima et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.